The burden of neutropenic sepsis in patients with advanced non-small cell lung cancer treated with single-agent docetaxel: A retrospective study-Reference-Cited by-同舟云学术

The burden of neutropenic sepsis in patients with advanced non-small cell lung cancer treated with single-agent docetaxel: A retrospective study

Published:2017-11 Issue: Volume:113 Page:115-120
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Talbot Toby,Dangoor Adam,Shah Riyaz,Naik Jay,Talbot Denis,Lester Jason F.,Cipelli Riccardo,Hodgson Matt,Patel Ajay,Summerhayes Max,Newsom-Davis Thomas

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference21 articles.

1. Considerations for second-line therapy of non-small cell lung cancer;Stinchcombe;Oncologist,2008

2. From 2000 to 2016: which second-line treatment in advanced non-small cell lung cancer?;D’Argento;Curr. Treat. Options Oncol.,2016

3. Second-line chemotherapy for non-small cell lung cancer;Bonfill;Cochrane Database Syst. Rev.,2001

4. Emerging therapeutic agents for lung cancer;Dholaria;J. Hematol. Oncol.,2016

5. Efficacy of tumor vaccines and cellular immunotherapies in non-small-cell lung cancer: a systematic review and meta-analysis;Dammeijer;J. Clin. Oncol.,2016

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Early switch from intravenous to oral antibiotic therapy in patients with cancer who have low-risk neutropenic sepsis: the EASI-SWITCH RCT;HEALTH TECHNOL ASSES;2024

2. Evaluating the impact of training on therapeutic radiographer awareness of the signs and symptoms of neutropenic sepsis in patients undergoing concurrent chemoradiotherapy;Radiography;2024-03

3. Construction of a Novel Bispecific Antibody to Enhance Antitumor Activity against Lung Cancer;Advanced Materials;2018-10-21